Literature DB >> 23901200

Malignant infantile osteopetrosis.

Kalenahalli Jagadish Kumar1, Kasi Bandaru, Sathya Narayana Prashanth, Sangaraju Mamatha.   

Abstract

Osteopetrosis, a rare congenital genetic disease characterized by increased bone density due to impaired bone resorption by osteoclasts. It is classified into three forms: Infantile malignant autosomal recessive (AR) osteopetrosis, intermediate (AR) osteopetrosis and autosomal dominant (AD) osteopetrosis. Incidence of infantile malignant AR is 1/2,00,000 and if untreated has a fatal outcome. The condition is commonly diagnosed in infancy with symptoms of significant hematologic abnormalities with bone marrow failure, hepatosplenomegaly, macrocephaly with frontal bossing and bone fractures. Because of rarity of this type of malignant infantile form of osteopretrosis, we like to report this case of malignant infantile osteopetrosis who presented with bronchopneumonia, anemia with melaena at 2 months 15 days of age.

Entities:  

Keywords:  Fatal; genetic; hepatosplenomegaly; infancy; malignant infantile osteopetrosis

Year:  2013        PMID: 23901200      PMCID: PMC3722638          DOI: 10.4103/0971-6866.112911

Source DB:  PubMed          Journal:  Indian J Hum Genet        ISSN: 1998-362X


  6 in total

1.  Malignant recessive osteopetrosis.

Authors:  S R Phadke; A Gupta; J Pahi; A Pandey; P Gautam; S S Agarwal
Journal:  Indian Pediatr       Date:  1999-01       Impact factor: 1.411

2.  Malignant infantile osteopetrosis presenting with neonatal hypocalcaemia.

Authors:  M Srinivasan; M Abinun; A J Cant; K Tan; A Oakhill; C G Steward
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-07       Impact factor: 5.747

3.  Novel mutations in Indian patients with autosomal recessive infantile malignant osteopetrosis.

Authors:  Shubha R Phadke; Bjoern Fischer; Neerja Gupta; Prajnya Ranganath; Madhulika Kabra; Uwe Kornak
Journal:  Indian J Med Res       Date:  2010-04       Impact factor: 2.375

4.  Autosomal recessive osteopetrosis: variability of findings at diagnosis and during the natural course.

Authors:  E J Gerritsen; J M Vossen; I H van Loo; J Hermans; M H Helfrich; C Griscelli; A Fischer
Journal:  Pediatrics       Date:  1994-02       Impact factor: 7.124

5.  A single-center experience in 20 patients with infantile malignant osteopetrosis.

Authors:  Evelina Mazzolari; Concetta Forino; Alessia Razza; Fulvio Porta; Anna Villa; Luigi Daniele Notarangelo
Journal:  Am J Hematol       Date:  2009-08       Impact factor: 10.047

6.  Clinical, genetic, and cellular analysis of 49 osteopetrotic patients: implications for diagnosis and treatment.

Authors:  A Del Fattore; B Peruzzi; N Rucci; I Recchia; A Cappariello; M Longo; D Fortunati; P Ballanti; M Iacobini; M Luciani; R Devito; R Pinto; M Caniglia; E Lanino; C Messina; S Cesaro; C Letizia; G Bianchini; H Fryssira; P Grabowski; N Shaw; N Bishop; D Hughes; R P Kapur; H K Datta; A Taranta; R Fornari; S Migliaccio; A Teti
Journal:  J Med Genet       Date:  2005-08-23       Impact factor: 6.318

  6 in total
  4 in total

1.  An infant with splenohepatomegaly: a rare cause.

Authors:  Kathiravan Kalyanasundaram; Podhini Jegadeesan; Sibi Chakravarthy Mohan; Vinoth N Ponnurangam
Journal:  J Clin Imaging Sci       Date:  2014-08-30

2.  Osteomyelitis of the mandible secondary to malignant infantile osteopetrosis in an adult.

Authors:  Louise Dunphy; Adrian Warfield; Rhodri Williams
Journal:  BMJ Case Rep       Date:  2019-03-20

3.  Whole exome sequencing identified two novel homozygous missense variants in the same codon of CLCN7 underlying autosomal recessive infantile malignant osteopetrosis in a Pakistani family.

Authors:  Muhammad Aman Khan; Aman Ullah; Muhammad Naeem
Journal:  Mol Biol Rep       Date:  2018-06-20       Impact factor: 2.316

Review 4.  Assessing the Efficacy of Alkylating Agent Regimens in the Treatment of Infantile Malignant Osteopetrosis: Cyclophosphamide, Busulfan, or Thiotepa.

Authors:  Himanshu Wagh; Amber Arif; Akshay J Reddy; Ethan Tabaie; Aditya Shekhar; Mildred Min; Neel Nawathey; Mark Bachir; Hetal Brahmbhatt
Journal:  Cureus       Date:  2022-07-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.